BiaCure™ Therapies
Redefining Healthcare Standards: The Wisconsin Leaders Bringing Breakthrough Medical Solutions to Life.
Innovation isn’t just about discovering new technologies—it’s about assembling the right team of experts to solve the most pressing unmet clinical needs. This belief has fueled every venture led by Laura King.
BiaCure is more than just another startup. It is the culmination of decades of expertise in medical technology, dermatology, and engineering innovation—a testament to the power of determined problem-solvers who refuse to accept the status quo.
Together, Laura King, Molly Hinshaw; M.D., and Rick Schefelker have joined forces once again to build BiaCure Therapies, a company on a mission to redefine the standard of care for onychomycosis (nail fungus). Their approach is rooted in science-driven solutions, patient-centered innovation, and a shared commitment to delivering a real cure—not just another temporary fix.
A Partnership Built on Transformative Solutions
Laura King, President and CEO of BiaCure Therapies, is a serial entrepreneur with a deep history of leading medical innovation. With a distinguished career at GE Healthcare, she honed her expertise in business transformation and disruptive technologies, shaping the future of healthcare solutions.
One of those successes was NeuWave Medical, which Laura co-founded alongside Rick Schefelker. The company’s groundbreaking thermal ablation technology revolutionized minimally invasive tumor treatment, ultimately leading to its acquisition by Johnson & Johnson.
Now, BiaCure is the second company Laura and Rick have partnered on, bringing their proven track record in precision energy, thermal engineering, and medical product development to the fight against onychomycosis.
A Clinical Expert Dedicated to Patient-Centered Innovation
At the foundation of BiaCure’s medical breakthrough is Dr. Molly Hinshaw, an internationally recognized expert in dermatology and a leading authority in nail disease.
As a dual-boarded dermatologist and dermatopathologist, Dr. Hinshaw brings an unmatched depth of expertise in diagnosing and treating onychomycosis. She has spent decades on the front lines of patient care, witnessing firsthand the frustrations of outdated treatments—and the lack of real, effective options.
Her contributions to the field earned her the Rose Hirschler Award, a prestigious honor recognizing outstanding advancements in dermatology.
As Founder and Chief Medical Officer, Dr. Hinshaw is ensuring BiaCure’s technology is clinically validated, scientifically rigorous, and optimized for real-world use.
A Shared Mission: Delivering a Cure Beyond the Surface
Onychomycosis—a persistent, often painful nail fungus—is more than a cosmetic concern; it’s a widespread medical condition affecting 35 million people in the U.S. and 430 million worldwide. Despite its prevalence, only a fraction of those affected seek treatment, largely due to the slow, ineffective, and inconvenient nature of existing options.
With a $4.5 billion global market, the demand for a truly effective and convenient treatment has never been greater. Current therapies—such as topical treatments requiring nearly a year of daily applications and systemic medications with significant side effects—fail to provide a definitive cure.
Furthering its dedication to scientific validation, BiaCure has established partnerships with leading laboratory to rigorously test and confirm the technology’s ability to successfully eradicate the onychomycosis fungus, further leveraging Wisconsin’s innovation ecosystem. This collaboration represents a crucial step in demonstrating the effectiveness of BiaCure’s innovative approach, reinforcing our reputation as a leader in biomedical research and technology development.
BiaCure Therapies is poised to revolutionize this outdated standard of care with a first-of-its-kind solution that doesn’t just clear the nail—it delivers a real cure.
Leading a New Era of Innovation
“At BiaCure Therapies, innovation is more than just developing breakthrough technology—it’s about the people who bring that innovation to life. I firmly believe that the success of any great company is built on a team of passionate, driven individuals who challenge the status quo, think boldly, and work relentlessly to make a real difference
The people we hire at BiaCure are not just employees; they are problem-solvers, visionaries, and changemakers. Every person on our team plays a critical role in pushing boundaries, refining ideas, and turning complex challenges into transformative solutions.
With BiaCure, the future of onychomycosis treatment isn’t just about clearer nails—it’s about delivering a true, lasting cure. The standard of care is changing, and BiaCure Therapies is leading the way.”
